Effect of dietary calcium supplementation on blood pressure and calciotropic hormones in mineralocorticoid-salt hypertension

D. J. DiPette, P. E. Greilich, G. A. Nickols, G. A. Graham, A. Green, C. W. Cooper, O. B. Holland

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

In order to determine the effect of dietary calcium supplementation on blood pressure and calciotropic hormones, we studied two groups (n = 12 each) of mineralocorticoid [deoxycorticosterone (DOC)]-salt hypertensive rats, one receiving a normal-calcium diet (0.6% calcium, as calcium carbonate) and the other a high-calcium diet (2.5% calcium), over an 8-week period. Dietary calcium supplementation significantly attenuated the rise in blood pressure. Serum ionized calcium concentrations were significantly decreased from baseline levels in both groups but tended to be higher among the calcium-supplemented rats. Serum concentrations of parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D3 (1,25-D) were significantly higher in the DOC-salt rats than in normotensive rats fed normal rat chow [PTH: 49 ± 4 versus 15 ± 0.9 pg/ml (means ± s.e.m.); 1,25-D: 108 ± 7 versus 73 ± 13 pg/ml, in DOC-salt and normotensive rats, respectively]. In the DOC-salt rats, dietary calcium supplementation did not significantly lower the elevated serum concentration of PTH (from 49 ± 4 to 40 ± 4 pg/ml; NS), but did significantly reduce that of 1,25-D (from 108 ± 7 to 66 ± 8 pg/ml; P < 0.01). Since 1,25-D may increase vascular smooth muscle calcium uptake, dietary calcium supplementation may lower blood pressure in DOC-salt hypertension, in part, by suppressing 1,25-D.

Original languageEnglish (US)
Pages (from-to)515-520
Number of pages6
JournalJournal of Hypertension
Volume8
Issue number6
DOIs
StatePublished - 1990

Fingerprint

Dietary Calcium
Mineralocorticoids
Dietary Supplements
Desoxycorticosterone
Salts
Hormones
Blood Pressure
Hypertension
Calcium
Parathyroid Hormone
Serum
Diet
Calcium Carbonate
Calcitriol
Vascular Smooth Muscle

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology

Cite this

DiPette, D. J., Greilich, P. E., Nickols, G. A., Graham, G. A., Green, A., Cooper, C. W., & Holland, O. B. (1990). Effect of dietary calcium supplementation on blood pressure and calciotropic hormones in mineralocorticoid-salt hypertension. Journal of Hypertension, 8(6), 515-520. https://doi.org/10.1097/00004872-199006000-00003

Effect of dietary calcium supplementation on blood pressure and calciotropic hormones in mineralocorticoid-salt hypertension. / DiPette, D. J.; Greilich, P. E.; Nickols, G. A.; Graham, G. A.; Green, A.; Cooper, C. W.; Holland, O. B.

In: Journal of Hypertension, Vol. 8, No. 6, 1990, p. 515-520.

Research output: Contribution to journalArticle

DiPette, D. J. ; Greilich, P. E. ; Nickols, G. A. ; Graham, G. A. ; Green, A. ; Cooper, C. W. ; Holland, O. B. / Effect of dietary calcium supplementation on blood pressure and calciotropic hormones in mineralocorticoid-salt hypertension. In: Journal of Hypertension. 1990 ; Vol. 8, No. 6. pp. 515-520.
@article{1885b94d676f45c0b194f3bf6918f5d1,
title = "Effect of dietary calcium supplementation on blood pressure and calciotropic hormones in mineralocorticoid-salt hypertension",
abstract = "In order to determine the effect of dietary calcium supplementation on blood pressure and calciotropic hormones, we studied two groups (n = 12 each) of mineralocorticoid [deoxycorticosterone (DOC)]-salt hypertensive rats, one receiving a normal-calcium diet (0.6{\%} calcium, as calcium carbonate) and the other a high-calcium diet (2.5{\%} calcium), over an 8-week period. Dietary calcium supplementation significantly attenuated the rise in blood pressure. Serum ionized calcium concentrations were significantly decreased from baseline levels in both groups but tended to be higher among the calcium-supplemented rats. Serum concentrations of parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D3 (1,25-D) were significantly higher in the DOC-salt rats than in normotensive rats fed normal rat chow [PTH: 49 ± 4 versus 15 ± 0.9 pg/ml (means ± s.e.m.); 1,25-D: 108 ± 7 versus 73 ± 13 pg/ml, in DOC-salt and normotensive rats, respectively]. In the DOC-salt rats, dietary calcium supplementation did not significantly lower the elevated serum concentration of PTH (from 49 ± 4 to 40 ± 4 pg/ml; NS), but did significantly reduce that of 1,25-D (from 108 ± 7 to 66 ± 8 pg/ml; P < 0.01). Since 1,25-D may increase vascular smooth muscle calcium uptake, dietary calcium supplementation may lower blood pressure in DOC-salt hypertension, in part, by suppressing 1,25-D.",
author = "DiPette, {D. J.} and Greilich, {P. E.} and Nickols, {G. A.} and Graham, {G. A.} and A. Green and Cooper, {C. W.} and Holland, {O. B.}",
year = "1990",
doi = "10.1097/00004872-199006000-00003",
language = "English (US)",
volume = "8",
pages = "515--520",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Effect of dietary calcium supplementation on blood pressure and calciotropic hormones in mineralocorticoid-salt hypertension

AU - DiPette, D. J.

AU - Greilich, P. E.

AU - Nickols, G. A.

AU - Graham, G. A.

AU - Green, A.

AU - Cooper, C. W.

AU - Holland, O. B.

PY - 1990

Y1 - 1990

N2 - In order to determine the effect of dietary calcium supplementation on blood pressure and calciotropic hormones, we studied two groups (n = 12 each) of mineralocorticoid [deoxycorticosterone (DOC)]-salt hypertensive rats, one receiving a normal-calcium diet (0.6% calcium, as calcium carbonate) and the other a high-calcium diet (2.5% calcium), over an 8-week period. Dietary calcium supplementation significantly attenuated the rise in blood pressure. Serum ionized calcium concentrations were significantly decreased from baseline levels in both groups but tended to be higher among the calcium-supplemented rats. Serum concentrations of parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D3 (1,25-D) were significantly higher in the DOC-salt rats than in normotensive rats fed normal rat chow [PTH: 49 ± 4 versus 15 ± 0.9 pg/ml (means ± s.e.m.); 1,25-D: 108 ± 7 versus 73 ± 13 pg/ml, in DOC-salt and normotensive rats, respectively]. In the DOC-salt rats, dietary calcium supplementation did not significantly lower the elevated serum concentration of PTH (from 49 ± 4 to 40 ± 4 pg/ml; NS), but did significantly reduce that of 1,25-D (from 108 ± 7 to 66 ± 8 pg/ml; P < 0.01). Since 1,25-D may increase vascular smooth muscle calcium uptake, dietary calcium supplementation may lower blood pressure in DOC-salt hypertension, in part, by suppressing 1,25-D.

AB - In order to determine the effect of dietary calcium supplementation on blood pressure and calciotropic hormones, we studied two groups (n = 12 each) of mineralocorticoid [deoxycorticosterone (DOC)]-salt hypertensive rats, one receiving a normal-calcium diet (0.6% calcium, as calcium carbonate) and the other a high-calcium diet (2.5% calcium), over an 8-week period. Dietary calcium supplementation significantly attenuated the rise in blood pressure. Serum ionized calcium concentrations were significantly decreased from baseline levels in both groups but tended to be higher among the calcium-supplemented rats. Serum concentrations of parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D3 (1,25-D) were significantly higher in the DOC-salt rats than in normotensive rats fed normal rat chow [PTH: 49 ± 4 versus 15 ± 0.9 pg/ml (means ± s.e.m.); 1,25-D: 108 ± 7 versus 73 ± 13 pg/ml, in DOC-salt and normotensive rats, respectively]. In the DOC-salt rats, dietary calcium supplementation did not significantly lower the elevated serum concentration of PTH (from 49 ± 4 to 40 ± 4 pg/ml; NS), but did significantly reduce that of 1,25-D (from 108 ± 7 to 66 ± 8 pg/ml; P < 0.01). Since 1,25-D may increase vascular smooth muscle calcium uptake, dietary calcium supplementation may lower blood pressure in DOC-salt hypertension, in part, by suppressing 1,25-D.

UR - http://www.scopus.com/inward/record.url?scp=0025078969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025078969&partnerID=8YFLogxK

U2 - 10.1097/00004872-199006000-00003

DO - 10.1097/00004872-199006000-00003

M3 - Article

C2 - 2165085

AN - SCOPUS:0025078969

VL - 8

SP - 515

EP - 520

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 6

ER -